This albumin-binding nanoparticle targets mannose receptors on M2 and pro-tumor M2 in patients with glioma and inhibits the glioma cell growth and proliferation by reprogramming pro-tumor M2 into anti-tumor M1-like macrophages (Fig. 2b) [39]. Here, ALB is linked to glioma.